US Patent Issued to BLUEPRINT MEDICINES on Feb. 10 for "CDK2 inhibitors" (Massachusetts Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,684, issued on Feb. 10, was assigned to BLUEPRINT MEDICINES Corp. (Cambridge, Mass.).

"CDK2 inhibitors" was invented by Douglas Wilson (Ayer, Mass.), Neil Bifulco Jr. (Sudbury, Mass.), Natasja Brooijmans (Boston), Joseph L. Kim (Wayland, Mass.), Philip D. Ramsden (Cambridge, Mass.), Richard Vargas (Cambridge, Mass.) and Steven Mark Wenglowsky (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a compound represented by structural Formula (I):or a pharmaceutically acceptable salt thereof useful for treating a cancer."

The patent was filed on March 14, 2024, under Application No. 18/605,248.

*For further ...